Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113883.3.464.1003.106.12.1005 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.12.1005 |
version | 20210220 |
status | active |
publisher | NCQA PHEMUR |
name | SubstanceUseDisorderTreatment |
title | Substance Use Disorder Treatment |
date | 2022-03-03T18:46:01-05:00 |
experimental | false |
Usages | (none) |
This value set contains 59 concepts
Code | System | Display |
171047005 | http://snomed.info/sct | Drugs of addiction education (procedure) |
20093000 | http://snomed.info/sct | Alcohol rehabilitation and detoxification (regime/therapy) |
23915005 | http://snomed.info/sct | Combined alcohol and drug rehabilitation and detoxification (regime/therapy) |
24165007 | http://snomed.info/sct | Alcoholism counseling (procedure) |
266707007 | http://snomed.info/sct | Drug addiction therapy (regime/therapy) |
310653000 | http://snomed.info/sct | Drug addiction therapy using methadone (regime/therapy) |
313071005 | http://snomed.info/sct | Counseling for substance abuse (procedure) |
370881007 | http://snomed.info/sct | Abuse prevention assessment (procedure) |
370884004 | http://snomed.info/sct | Abuse prevention management (procedure) |
385989002 | http://snomed.info/sct | Substance use therapy (regime/therapy) |
386448003 | http://snomed.info/sct | Substance use prevention (procedure) |
386449006 | http://snomed.info/sct | Substance use treatment: alcohol withdrawal (regime/therapy) |
386450006 | http://snomed.info/sct | Substance use treatment: drug withdrawal (regime/therapy) |
386451005 | http://snomed.info/sct | Substance use treatment: overdose (regime/therapy) |
408933008 | http://snomed.info/sct | Substance abuse prevention (procedure) |
408934002 | http://snomed.info/sct | Substance abuse prevention assessment (procedure) |
408935001 | http://snomed.info/sct | Substance abuse prevention education (procedure) |
408936000 | http://snomed.info/sct | Substance abuse prevention management (procedure) |
408941008 | http://snomed.info/sct | Drug abuse prevention (procedure) |
408942001 | http://snomed.info/sct | Drug abuse prevention assessment (procedure) |
408943006 | http://snomed.info/sct | Drug abuse prevention education (procedure) |
408944000 | http://snomed.info/sct | Drug abuse prevention management (procedure) |
408945004 | http://snomed.info/sct | Alcohol abuse prevention (procedure) |
408947007 | http://snomed.info/sct | Alcohol abuse prevention education (procedure) |
408948002 | http://snomed.info/sct | Alcohol abuse prevention management (procedure) |
410419007 | http://snomed.info/sct | Substance use surveillance (regime/therapy) |
413473000 | http://snomed.info/sct | Counseling about alcohol consumption (procedure) |
423416000 | http://snomed.info/sct | Substance use cessation case management (procedure) |
424148004 | http://snomed.info/sct | Substance use cessation surveillance (regime/therapy) |
424407005 | http://snomed.info/sct | Substance use cessation education, guidance, and counseling (procedure) |
424589009 | http://snomed.info/sct | Substance use treatment: cessation (regime/therapy) |
426928008 | http://snomed.info/sct | Prevention of opioid abuse (procedure) |
429291000124102 | http://snomed.info/sct | Alcohol brief intervention (procedure) |
56876005 | http://snomed.info/sct | Drug rehabilitation and detoxification (regime/therapy) |
60112009 | http://snomed.info/sct | Drug addiction counseling (procedure) |
707166002 | http://snomed.info/sct | Alcohol reduction program (regime/therapy) |
720174008 | http://snomed.info/sct | Drug harm reduction program (regime/therapy) |
720175009 | http://snomed.info/sct | Alcohol harm reduction program (regime/therapy) |
720176005 | http://snomed.info/sct | Alcohol relapse prevention program (regime/therapy) |
720177001 | http://snomed.info/sct | Drug relapse prevention program (regime/therapy) |
737363002 | http://snomed.info/sct | Alcohol abuse surveillance (regime/therapy) |
792901003 | http://snomed.info/sct | Drug addiction therapy using buprenorphine (regime/therapy) |
792902005 | http://snomed.info/sct | Drug addiction therapy using buprenorphine and naloxone (regime/therapy) |
G2067 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2068 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2069 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2070 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2071 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2072 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2073 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2074 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2075 | http://www.nlm.nih.gov/research/umls/hcpcs | Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) |
G2076 | http://www.nlm.nih.gov/research/umls/hcpcs | Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient's short-term goals and the tasks the patient must perform to complete the short-term goals; the patient's requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
G2077 | http://www.nlm.nih.gov/research/umls/hcpcs | Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
G2080 | http://www.nlm.nih.gov/research/umls/hcpcs | Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
G2086 | http://www.nlm.nih.gov/research/umls/hcpcs | Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month |
G2087 | http://www.nlm.nih.gov/research/umls/hcpcs | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month |
H0020 | http://www.nlm.nih.gov/research/umls/hcpcs | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
H0033 | http://www.nlm.nih.gov/research/umls/hcpcs | Oral medication administration, direct observation |
Produced 08 Sep 2023